Annual ROE
169.78%
+407.61%+171.39%
31 December 2023
Summary:
Akebia Therapeutics annual return on equity is currently 169.78%, with the most recent change of +407.61% (+171.39%) on 31 December 2023. During the last 3 years, it has risen by +289.60% (+241.70%). AKBA annual ROE is now -44.49% below its all-time high of 305.88%, reached on 31 December 2012.AKBA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
129.56%
+6.09%+4.93%
30 September 2024
Summary:
Akebia Therapeutics quarterly return on equity is currently 129.56%, with the most recent change of +6.09% (+4.93%) on 30 September 2024. Over the past year, it has dropped by -181.56% (-58.36%). AKBA quarterly ROE is now -58.36% below its all-time high of 311.12%, reached on 30 September 2023.AKBA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +171.4% | -58.4% |
| 3 y3 years | +241.7% | +194.1% |
| 5 y5 years | +548.4% | +346.4% |
AKBA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +171.4% | -58.4% | +110.6% |
| 5 y | 5 years | at high | +171.4% | -58.4% | +110.6% |
| alltime | all time | -44.5% | +171.4% | -58.4% | +110.6% |
Akebia Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 129.56%(+4.9%) |
| June 2024 | - | 123.47%(-11.0%) |
| Mar 2024 | - | 138.73%(-25.7%) |
| Dec 2023 | 169.78%(-171.4%) | 186.83%(-39.9%) |
| Sept 2023 | - | 311.12%(-125.5%) |
| June 2023 | - | -1220.85%(+294.9%) |
| Mar 2023 | - | -309.16%(+20.5%) |
| Dec 2022 | -237.83%(+35.6%) | -256.57%(+2.5%) |
| Sept 2022 | - | -250.35%(+46.2%) |
| June 2022 | - | -171.21%(-22.0%) |
| Mar 2022 | - | -219.61%(+32.0%) |
| Dec 2021 | -175.37%(+46.4%) | -166.43%(+20.9%) |
| Sept 2021 | - | -137.71%(+21.2%) |
| June 2021 | - | -113.62%(-10.8%) |
| Mar 2021 | - | -127.31%(+14.3%) |
| Dec 2020 | -119.82%(+120.8%) | -111.42%(+11.0%) |
| Sept 2020 | - | -100.40%(+11.9%) |
| June 2020 | - | -89.74%(+57.0%) |
| Mar 2020 | - | -57.15%(+5.6%) |
| Dec 2019 | -54.27% | -54.11%(+2.9%) |
| Sept 2019 | - | -52.58%(-1.5%) |
| June 2019 | - | -53.37%(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -56.38%(-0.7%) |
| Dec 2018 | -37.86%(-51.0%) | -56.80%(+21.6%) |
| Sept 2018 | - | -46.71%(-7.8%) |
| June 2018 | - | -50.66%(-2.2%) |
| Mar 2018 | - | -51.81%(-46.8%) |
| Dec 2017 | -77.27%(-43.3%) | -97.40%(-45.4%) |
| Sept 2017 | - | -178.29%(-18.5%) |
| June 2017 | - | -218.73%(+17.8%) |
| Mar 2017 | - | -185.72%(+60.7%) |
| Dec 2016 | -136.35%(+194.2%) | -115.56%(+30.7%) |
| Sept 2016 | - | -88.40%(+26.5%) |
| June 2016 | - | -69.90%(+36.9%) |
| Mar 2016 | - | -51.06%(+9.5%) |
| Dec 2015 | -46.35%(+30.3%) | -46.64%(+12.4%) |
| Sept 2015 | - | -41.49%(+16.6%) |
| June 2015 | - | -35.58%(+1.5%) |
| Mar 2015 | - | -35.06%(+10.6%) |
| Dec 2014 | -35.58%(-16.9%) | -31.71%(-4.3%) |
| Sept 2014 | - | -33.13%(+14.5%) |
| June 2014 | - | -28.94%(+3.2%) |
| Mar 2014 | - | -28.05%(-34.5%) |
| Dec 2013 | -42.81%(-114.0%) | -42.81% |
| Dec 2012 | 305.88% | - |
FAQ
- What is Akebia Therapeutics annual return on equity?
- What is the all time high annual ROE for Akebia Therapeutics?
- What is Akebia Therapeutics annual ROE year-on-year change?
- What is Akebia Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly ROE year-on-year change?
What is Akebia Therapeutics annual return on equity?
The current annual ROE of AKBA is 169.78%
What is the all time high annual ROE for Akebia Therapeutics?
Akebia Therapeutics all-time high annual return on equity is 305.88%
What is Akebia Therapeutics annual ROE year-on-year change?
Over the past year, AKBA annual return on equity has changed by +407.61% (+171.39%)
What is Akebia Therapeutics quarterly return on equity?
The current quarterly ROE of AKBA is 129.56%
What is the all time high quarterly ROE for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly return on equity is 311.12%
What is Akebia Therapeutics quarterly ROE year-on-year change?
Over the past year, AKBA quarterly return on equity has changed by -181.56% (-58.36%)